Orthotics and Prosthetics Outcomes
Released: February 8, 2023
Department of Defense
Congressionally Directed Medical Research Programs (CDMRP)
Orthotics and Prosthetics Outcomes Research Program
Anticipated Funding Opportunities for Fiscal Year 2023 (FY23)
The FY23 Defense Appropriations Act provides funding for the Orthotics and Prosthetics Outcomes Research Program (OPORP) to support research that evaluates orthoses and/or prostheses using patient-centric outcomes relevant to the Service Member and military beneficiaries, Veterans, and other individuals with limb loss and/or limb impairment. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC).
The OPORP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY23 funding opportunities. This pre-announcement should not be construed as an obligation by the government. The FY23 OPORP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the announcements are released.
In order to attain the highest possible quality of life for individuals with limb loss and limb impairment, the OPORP supports research on outcomes-based best practices through analysis of prosthetic and/or orthotic device options that are currently available, and not on the development of new devices or the improvement of an existing technology. Development and employment of new approaches and tools for measuring outcomes is allowed and encouraged. New for FY23, the OPORP is interested in expanding the impact of the research within the OPORP portfolio by funding orthotic- and prosthetic-outcomes research to include, but not limited to, topics in injury and trauma, stroke, neuropathy, diabetes, vascular disease, and/or infection. Projects involving spinal orthoses, pediatric populations, or exclusively addressing therapeutic insoles will not be considered for the FY23 OPORP.
Applications submitted to the FY23 OPORP must address one or more of the following Strategic Goals:
- Optimize patient-specific technology prescription. Applications submitted to this goal should focus on identifying optimal (1) devices and device characteristics, (2) human interface with devices, and/or (3) intuitive control systems, all grounded in an understanding of the requirements of patient-specific needs and the capabilities and limitation of available devices.
- Optimize patient-specific rehabilitation regimens. Applications submitted to this goal should address the cause and effect of an orthotic or prosthetic device on optimal type, timing, and dosing (e.g. duration, frequency, intensity) of rehabilitation for each individual in the context of each person’s unique requirements and preferences. Efforts that also address the impact of provider competencies and patient training on the effectiveness of the rehabilitation regimen, as well as efforts to identify the best approaches to mitigate secondary health deficits, are encouraged.
- Support standardized assessment of patient outcomes related to prosthetics and orthotics. Applications submitted to this goal should seek to validate function and performance, community integration, and user satisfaction outcomes associated with various device properties and functional abilities. An important objective of this goal is to enhance the understanding of the outcomes that matter most for individuals living with orthotic and prosthetic devices.
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Clinical Research Award||Independent investigators at all academic levels (or equivalent)||
Research Level 1
|Clinical Trial Award||Independent investigators at all academic levels (or equivalent)||
Research Level 1
A pre-application is required and must be submitted through the Biomedical Research Application Portal (eBRAP) prior to the pre-application deadline. All applications must conform to the final funding opportunity announcements that will be available for downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the funding opportunity announcements are released. For email notification when announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage. For more information about the OPORP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.health.mil).
Point of Contact:
CDMRP Public Affairs
Last updated Sunday, December 31, 1600